Fatty Liver and Cardiovascular Disease: Partners in Crime?
Webinar from March 3, 2021
Nonalcoholic fatty liver disease (NAFLD), is a common condition and it is projected to become the first cause of liver transplant in Europe and United States. The disease comprises a spectrum of conditions from steatosis to steatohepatitis, fibrosis and ultimately to cirrhosis and cancer. Interestingly, NAFLD also strongly coexists with dyslipidemia and individuals with NAFLD often present with cardiovascular disease. In this webinar the speakers will report on the current knowledge of NAFLD focusing on the cardiovascular risk aspects. The presentations are given by three front-line researchers in the field.